Good morning all, let's see what we've got in store for us today!
Companies Reporting
Name (Mkt Cap) | RNS | Summary | Our view (Author) |
---|---|---|---|
AstraZeneca (LON:AZN) (£163bn) | Rev +10%, adj EPS +21% to $2.49. FY25 guidance unchanged, five positive Phase III readouts. | ||
HSBC Holdings (LON:HSBA) (£147bn) | Adj PBT +11% to $9.8bn, RoTE 17.9%. Q1 divi of $0.10, $3bn buyback. Volatile macro outlook. | ||
BP (LON:BP.) (£57.8bn) | Und. RC profit $1.4bn (4Q24: $1.2bn). Divi 8 cents, $0.75bn buyback. Outlook mixed. | AMBER/RED (Roland) Today’s Q1 numbers appear to have missed expectations and flag up a sharp rise in debt. The company is accelerating asset sales and believes it remains on track to hit 2027 financial targets. However, oil prices are now below the level on which February’s guidance was based. BP’s higher leverage and sector underperformance also makes me cautious, given the uncertain external conditions. There could be value on offer here. But I think BP’s Value Trap styling is a timely warning that the stock may deserve a lower rating than peers. | |
Coca-Cola Europacific Partners (LON:CCEP) (£30.2bn) | Q1 in line, rev +5%, volumes +7.8%. FY25 guidance unchanged. | ||
Associated British Foods (LON:ABF) (£16.2bn) | Rev -2%, adj PBT -10% to £818m. £101m impairment in Sugar. FY outlook unchanged. | AMBER (Roland) [no section below] Today’s half-year results confirm that performance in the group’s Primark and Grocery business is on track to meet full-year expectations. However, the Sugar business is now expected to report an operating loss of up to £40m due to low sugar prices and some structural and regulatory issues. Restructuring efforts are underway. Frustratingly there’s no clear guidance on the impact to group profit expectations this year. However, based on previous guidance, I estimate a c.5% reduction in group earnings, which would be consistent with today’s share price fall. ABF was a Super Stock prior to today and I think the shares are probably reasonably priced on a long-term view. However, I think a neutral stance is more appropriate following today’s update. | |
Beazley (LON:BEZ) (£5.6bn) | Written premiums +2%, renewal rates -4%. Guidance unchanged for FY combined ratio in “mid-80s”. | ||
Howden Joinery (LON:HWDN) (£4.1bn) | Adj rev +3%, LFL +1.8%. Double-digit intl growth. Balancing margin and volume. FY in line. | ||
Entain (LON:ENT) (£4.0bn) | Q1 rev +11%,… |